Document Detail

Evaluation of induction doses of propofol: comparison between endstage renal disease and normal renal function patients.
MedLine Citation:
PMID:  12413256     Owner:  NLM     Status:  MEDLINE    
Anaemia, hypoproteinaemia and acidic pH in renal failure patients can alter the pharmacokinetics and pharmacodynamics of anaesthetic agents, resulting in altered dose requirements. We evaluated the induction dose of propofol in adult patients with end-stage renal disease by titrating the hypnotic effect by means of a clinical parameter as well as using a more objective assessment of hypnosis, the Bispectral Index (BIS) monitor. The dose was compared with that for patients with normal renal function. Propofol doses that provided the clinical end-point of hypnosis (syringe drop method), as well as the end-point of a mean (SD) BIS value of 50 (5), were evaluated in 27 end-stage renal disease and 27 normal renal function patients. Propofol was administered at 0.2 mg/kg every 15 seconds until these end-points were achieved. End-stage renal disease patients required significantly higher propofol doses to achieve the clinical end-point of hypnosis (1.42 (0.24) mg/kg versus 0.89 (0.2) mg/kg in normal renalfunction patients, P<0.05 unpaired "t" test). Propofol dose required to achieve a BIS of 50 (5) was also higher in end-stage renal disease patients (2.03 (0.4) mg/kg versus 1.39 (0.43) mg/kg in normal renal function patients, P<0.05). There was a significant negative correlation of propofol dose with preoperative haemoglobin concentration. A hyperdynamic circulation in renal failure patients with anaemia may be responsible for the higher propofol dose requirement in this group.
P Goyal; G D Puri; C K Pandey; S Srivastva
Related Documents :
2383376 - Dopaminergic modulation of acute renal effects of nicardipine.
19528286 - Assessment of the effects of the nitroimidazo-oxazine pa-824 on renal function in healt...
8334826 - Segmental tubular sodium reabsorption in type 1 diabetes.
11280636 - Low-dose dopamine in neonatal and pediatric intensive care: a systematic review.
19767606 - Relative potencies of bupivacaine, levobupivacaine, and ropivacaine for neonatal spinal...
1355736 - Effects of dopamine receptor agonists on passive avoidance learning in mice: interactio...
Publication Detail:
Type:  Comparative Study; Evaluation Studies; Journal Article    
Journal Detail:
Title:  Anaesthesia and intensive care     Volume:  30     ISSN:  0310-057X     ISO Abbreviation:  Anaesth Intensive Care     Publication Date:  2002 Oct 
Date Detail:
Created Date:  2002-11-04     Completed Date:  2003-02-14     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0342017     Medline TA:  Anaesth Intensive Care     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  584-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anesthesia Recovery Period
Anesthesia, Intravenous / methods
Anesthetics, Intravenous / administration & dosage*
Case-Control Studies
Dose-Response Relationship, Drug
Kidney Failure, Chronic / diagnosis*,  surgery
Kidney Function Tests
Kidney Transplantation / methods
Middle Aged
Monitoring, Intraoperative
Preoperative Care
Propofol / administration & dosage*,  adverse effects
Reference Values
Regression Analysis
Risk Assessment
Treatment Outcome
Reg. No./Substance:
0/Anesthetics, Intravenous; 2078-54-8/Propofol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Remifentanil concentration during target-controlled infusion of propofol.
Next Document:  Perioperative plasma concentrations of atrial and brain natriuretic peptides in patients undergoing ...